Ted Love

Ted Love

Direttore/Membro del Consiglio presso LISATA THERAPEUTICS, INC.

Patrimonio netto: 5 M $ in data 31/08/2026

67 anni
Health Technology
Commercial Services
Consumer Services

Profilo

Dr. Ted W.
Love
, MD, is an Independent Director at Jazz Pharmaceuticals Plc, an Independent Director at Gilead Sciences, Inc., an Independent Director at Structure Therapeutics, Inc. and a Lead Independent Director at Royalty Pharma Plc.
He is on the Board of Directors at Lisata Therapeutics, Inc., Jazz Pharmaceuticals Plc, Gilead Sciences, Inc., Structure Therapeutics, Inc., Royalty Pharma Plc, Avillion LLP, Biotechnology Innovation Organization and Life Science Cares Bay Area.
Dr. Love was previously employed as a Chairman by Marea Therapeutics, Inc., an Independent Director by Seagen, Inc., an Independent Director by Portola Pharmaceuticals LLC, a President, Chief Executive Officer & Director by Global Blood Therapeutics, Inc., an Independent Director by CASCADIAN THERAPEUTICS INC, an Independent Director by Mast Therapeutics, Inc., an Independent Director by Amicus Therapeutics, Inc., an Independent Director by Bio-Rad Laboratories, Inc., an Executive VP, Head-Research & Development by Onyx Pharmaceuticals, Inc., a Lead Independent Director by KaloBios Pharmaceuticals, Inc., an Independent Director by Affymax, Inc., an Independent Director by Santarus, Inc., a Chairman, President & Chief Executive Officer by Nuvelo, Inc., a Senior Vice President-Development by Theravance, Inc., a Senior Vice President-Development by Theravance Biopharma Us LLC, and a VP-Product Development & Regulatory Affairs by Genentech, Inc. He also served on the board at Anesiva, Inc., ARCA biopharma, Inc., California Institute for Regenerative Medicine, ARCA biopharma, Inc. /Old/, California Healthcare Institute, Predix Pharmaceuticals, Inc., Stanford Health Care-Stanford Hospital and The Biotechnology Institute.
He received his undergraduate degree from Haverford College and a doctorate degree from Yale School of Medicine.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
05/06/2026 58.393 ( 0,01% ) 4 M $ 31/08/2026
30/04/2026 5.484 ( 0% ) 802 529 $ 31/08/2026
31/08/2026 2.389 ( 0% ) 598 875 $ 31/08/2026
17/06/2026 0 ( -.--% ) - $ 31/08/2026

Posizioni attive di Ted Love

SocietàPosizioneInizio
ROYALTY PHARMA PLC Direttore/Membro del Consiglio 30/07/2020
LISATA THERAPEUTICS, INC. Direttore/Membro del Consiglio 17/09/2026
JAZZ PHARMACEUTICALS PLC Direttore/Membro del Consiglio 01/12/2025
GILEAD SCIENCES, INC. Direttore/Membro del Consiglio 01/02/2024
STRUCTURE THERAPEUTICS INC. Direttore/Membro del Consiglio 03/08/2023
Direttore/Membro del Consiglio 22/07/2013
Direttore/Membro del Consiglio 01/01/2025
Life Science Cares Bay Area
Direttore/Membro del Consiglio -

Precedenti posizioni note di Ted Love

SocietàPosizioneFine
SEAGEN INC. Direttore/Membro del Consiglio 14/12/2023
░░░░░░ ░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Ted Love

Formazione di Ted Love

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

66

Relazioni di 1° grado

33

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private33

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Consumer Services

Health Services

Health Technology

Government

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Consumer Services

Health Technology

Health Technology

Life Science Cares Bay Area

Commercial Services

Health Technology